🤩 Oligonucleotides for inhalation

MERXIN Ltd

We Make Inhalers - We Will Launch You - We Make It Better

Published May 7, 2024

Are inhaled oligonucleotide therapies possible?

Before I delve into this topic, let me introduce myself, I am Zaid, Business Development Manager at Merxin Ltd. I am new to the OINDP world and look forward to meeting you...

Merxin Ltd Newsletter

1,025 follower

+ Subscribe

To view or add a comment, sign in

Insights from the community

Statistics

How do you distinguish between a placebo and an active treatment?
Technological Innovation

What are the most effective market research methods for evaluating a new biotech product's market size?
Chemical Engineering

What is the best way to predict the pharmacokinetics of a drug?
Sample Preparation

How do you select the appropriate membrane size and type for buffer exchange and diafiltration?
Laboratory Management

You're setting up a new laboratory. Which reagents should you invest in?
Statistics

How can you identify causal effects with instrumental variables?
Outside Sales

How can you address client concerns about new drug side effects?
Market Access

What are the best practices for pricing and reimbursement strategies for biosimilars and generics?
Sample Preparation

How do you reduce sample variability and bias in biomarker studies?
Market Access

How do you assess the value proposition of a new drug for different payer segments?

Others also viewed

Nitazene Analogs

Aegis Sciences Corporation 1y
Featured Live Webcast

Pharmaceutical Technology 2mo
MOST CRITICAL IMPURITIES OF SUVOREXANT AVAILABLE READY STOCK IN KARPSCHEM

Mrs. Megha Nagare 1y
Alzheimer’s from the patient’s perspective

Tim Sandle, Ph.D., CBiol, FIScT 8y
A "smart insulin" therapeutic that inactivates itself during hypoglycemia

Ken Wasserman 4w
Cough is heating up

Joe Brew 1y
TOP10 reimbursement value in Poland - July 2023

HTA Consulting 1y
Glyconics Awarded Horizon 2020 Seal of Excellence

Kam Pooni 8y
MDMA Faces FDA Setback: SpravatoⓇ quietly expanding

Meeko Health 5mo
Combination Chemotherapy

Samir Mitragotri 7y

Explore topics

Sales
Marketing
IT Services
Business Administration
HR Management
Engineering
Soft Skills
See All

Merxin Ltd Newsletter

1,025 follower

More articles by MERXIN Ltd

👋 We're Back Bearing Gifts

🎅 Breathe & Lose Weight

🔺 I.P.ic Rise

⛑️ Sir Spend-A-Lot: PMI Sells Vectura

🕺 Death is overrated: long live OINDPs

🔥 HOT: SUMMER. Avoid the Olympics

⚽️ SMIs. It’s coming home.

🦄 Biologics and SMIs: Unicorns Spotting

Insights from the community

Others also viewed

Nitazene Analogs

Featured Live Webcast

MOST CRITICAL IMPURITIES OF SUVOREXANT AVAILABLE READY STOCK IN KARPSCHEM

Alzheimer’s from the patient’s perspective

A "smart insulin" therapeutic that inactivates itself during hypoglycemia

Cough is heating up

TOP10 reimbursement value in Poland - July 2023

Glyconics Awarded Horizon 2020 Seal of Excellence

MDMA Faces FDA Setback: SpravatoⓇ quietly expanding

Combination Chemotherapy

Explore topics